Investor's Attention Takers: Sigma Labs (OTCMKTS:SGLB), Deutsche Telekom (OTCMKTS:DTEGY), RXi Pharmaceuticals (OTCMKTS:RXII), Primco Management (OTCBB:PMCM)

Repost This

Chicago, IL -- (SBWIRE) -- 07/24/2013 -- prowls the markets, sifts through hundreds of companies and picks those positioned to move and then presents them to you. Stocks with the greatest possibility of gains, period. We call it as we see it and we are real about it. Let’s have a look at today’s hot stocks: Sigma Labs Inc(OTCMKTS:SGLB), Deutsche Telekom AG (ADR) (OTCMKTS:DTEGY), RXi Pharmaceuticals Corp (OTCMKTS:RXII), Primco Management Inc (OTCBB:PMCM)

Sigma Labs Inc(OTCMKTS:SGLB) percentage change dropped -8.40% to close at $0.109, with the total traded volume of 6.60 million shares, as compare to average volume of 4.40 million shares. SGLB’s lowest price during last trade was $0.11, while its highest price was $0.13 for the day. SGLB’s total market capitalization is $46.62 million. Its beta value stands at 6.44 points and its prior 5 days trend was +60.29%.

Should SGLB a Buy or Sell Now? Find Out Here

Sigma Labs, Inc. engages in the development and commercialization of manufacturing and materials technologies, and R&D solutions.

Deutsche Telekom AG (ADR) (OTCMKTS:DTEGY) opened at the price of $12.33, whereas its previous closing price was recorded at $12.38. DTEGY stayed at +2.31% and traded within the range of $12.28-$12.38 for the day. The 52 week range of the stock remained in between $10.34 - $13.06. Total volume of the stock was 471,611 shares during last trade, while its average volume remained 506,692 shares. Company’s total market capitalization stands at $53.47 billion, along with 4.32 billion outstanding shares.

Can DTEGY Show a Strong Recovery? Find out in This Research Report

Deutsche Telekom AG (ADR) (OTCMKTS:DTEGY) operates as an integrated telecommunication company worldwide.

On Tuesday, RXi Pharmaceuticals Corp (OTCMKTS:RXII) traded with the opening price at $0.16 and finished the business day at $4.41by showing an upbeat move of +2,763.64%. RXII exchanged 1.33 million shares on Tuesday, as compared to its average volume of 890,911 shares. Shares outstanding of the company remained 338.16 million and its EPS stand at $-0.24.

Where RXII is Headed Exactly? Find out in This Trend Analysis Reports

RXi Pharmaceuticals Corporation discovers, develops, and commercializes therapies based on its RNAi platform.
Primco Management Inc (OTCBB:PMCM) it’s Tuesday’s volume remained 74.92 million shares and its average volume remained 32.67 million shares. The stock was among bears and moved down -3.45%. Tracking the prior trends of different periods, like the stock’s 6 month and three month trends, both were negative, as it plunged -99.3%, -84.7%, respectively.

Is PMCM Buy After The Recent Price Movement? Find Out Here

Primco Management Inc. (PMCM), a fully integrated multi-media entertainment and real estate development company, is proud to announce that it has launched its first property development Joint Venture with highly renowned Whittier, California based property developer and construction company Total Resources Inc. The joint project, known as “Tuscany Villas,” is an upscale 60 townhouse development on a 3.55 acre site located in Corona, California, for which building approvals and tract divisions have already been obtained. \
Primco Management Inc., a development stage company, focuses on providing real estate management services.
For the best penny stock picks penny stocks visit us at

Our approach to penny stocks is completely different from most other sites out there. We prowl the markets, sift through hundreds of companies and pick those poised to move and then present them to you. Stocks with the greatest possibility of gains, period. We call it as we see it and we are real about it.

Please fully understand this disclaimer before using our site or joining our email list. If you have any questions please contact us at is a private membership service that specializes in providing opinions, comments and information on stocks to individuals who wish to receive them. Our reports are for information and entertainment purposes only and are distributed free of charge exclusively to individuals who wish to receive them.

Read More at: